What is the prevalence of self‑harm among adolescents in the United Kingdom?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prevalence of Self-Harm in UK Adolescents

Self-harm is highly prevalent among UK adolescents, affecting approximately 15-24% of young people aged 13-18 years, with rates varying by age, sex, and measurement methods.

Community-Based Prevalence Estimates

The most robust community-based data from England demonstrates substantial rates of self-harm:

  • Overall prevalence: 15.5% of adolescents aged 13-18 years reported ever having self-harmed in a nationally representative survey 1
  • 12-month prevalence: 24.1% of 17-year-olds reported self-harm in the previous year 2
  • Historical comparison: Earlier data from 2002 showed 6.9% of 15-16 year-olds reported self-harm in the previous year 3, suggesting rates have increased substantially over two decades

Age and Sex Patterns

Self-harm prevalence demonstrates clear demographic patterns:

  • Age of onset: Self-harm typically begins in early adolescence, aged 10-14 years, with median onset at 13.0 years 1
  • Peak incidence: Frequency peaks around age 16 years 4
  • Female predominance in younger adolescents: At age 14, females report 22.8% prevalence versus 8.5% in males 2
  • Narrowing gender gap: By age 17, the gap narrows considerably (females 28.2%, males 20.1%) 2, indicating males increasingly engage in self-harm as they age

High-Risk Subgroups

Certain populations demonstrate markedly elevated rates:

  • Sexual minority adolescents: Experience 2-4 times higher prevalence, with 55.8% reporting self-harm compared to 20.5% in heterosexual adolescents 2
  • Adolescents with disabilities: Show dramatically elevated rates, with lifetime suicide attempt prevalence of 21.9% for those with less limiting disabilities and 25.5% for those with more limiting disabilities, compared to 5.3% without disabilities 5
  • Those with mental health limitations: Demonstrate adjusted prevalence rate ratios of 5.13 for suicide attempts 5

Hospital Presentation Versus Community Rates

A critical caveat is the substantial gap between community prevalence and healthcare contact:

  • Only 12.6% of self-harm episodes result in hospital presentation 3
  • For every young female aged 12-17 who dies by suicide, there are approximately 1,000 episodes of hospital-presenting self-harm 4
  • This indicates that hospital-based statistics dramatically underestimate true community prevalence 4

Temporal Trends and Contextual Factors

  • Increasing rates: Non-fatal self-harm has increased over recent decades in both community and clinical settings 4
  • COVID-19 impact: During the first UK lockdown, 7.5% of adolescents reported self-harm during lockdown specifically, with 36.4% reporting increased loneliness 6
  • Sociodemographic inequalities: White adolescents, females, sexual minorities, and those from socioeconomically disadvantaged families demonstrate worse outcomes 2

Clinical Implications

Despite high community prevalence, healthcare system engagement remains inadequate:

  • One-quarter of young people presenting to emergency departments after self-harm do not receive psychosocial assessments 4
  • Of those assessed, only half are referred to outpatient treatment, and just over one-quarter of those referred attend at least one session 4
  • These rates have not meaningfully improved over time 4, representing a persistent gap in care delivery

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.